Q4 2024 Management View CEO Raymond Tesi highlighted the transformative potential of 2024 for INmune Bio, emphasizing upcoming milestones. He noted the Phase 2 trial of XPro for Alzheimer's disease, ...

INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, ...

Target Indications Also Include Peeling Skin Syndrome, SAM Syndrome, Palmoplantar Keratoderma and Severe Atopic Dermatitis; ...

Churchill Living retirement home owners and team members took to the streets of Calne to complete a sponsored walk to raise £100 for DEBRA.

Krystal Biotech's VYJUVEK, a first-mover gene therapy for DEB, has received a positive CHMP recommendation. Read why KRYS ...

Dilgen, a 22-year-old Tottenville resident, has been battling epidermolysis bullosa (EB), a rare, life-threatening genetic ...

Wellesley will host the eighth annual Plunge for Elodie raises money to benefit research programs for Epidermolysis bullosa, a rare skin disease.

This is the eighth year for these plunges at 21 locations in six different countries. Brooks is the 5-year-old son of former Barboursville residents Brian and Annie Keys Kendrick, and the grandson of ...